semaglutide and pregnancy Use of GLP-1 drugs early in should not cause alarm, analysis suggests Ozempic and Pregnancy: Can You

Excluding the inherent limitations that are known to exist with dietary self-reports, we expressed caloric intake relative to body mass, and based on the fact that there were no significant changes over the course of the 8-week study for the dietary variables, and that GSH + CIT did not consume more total calories or protein than the other two groups, dietary intake can likely be ruled out as a possible confounding variable for the increased lean mass

While insurers may point to diabetes, sleep apnea, or blood-pressure fluctuations as causes, a documented timeline showing a recent start or dose increase of a GLP-1 drug followed by sudden NAION strengthens a potential claim

IGF-1 increases laminin, cyclin D1, and P21Cip1 expression in glomerular mesangial cells: An investigation of the intracellular signaling pathway and cell-cycle progression

What these products are not: a treatment for obesity, diabetes, or any medical condition, and not an alternative to a GLP-1 medication